Etienne G C Brain

Summary

Country: France

Publications

  1. pmc First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
    Chrystelle Brignone
    Immutep SA, 2 rue Jean Rostand, Orsay 91893, France
    J Transl Med 8:71. 2010
  2. doi Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial
    Etienne G C Brain
    Institut Curie, Hôpital René Huguenin, Saint Cloud, France
    Crit Rev Oncol Hematol 80:160-70. 2011
  3. ncbi Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer
    Etienne G C Brain
    Department of Medical Oncology, René Huguenin Cancer Centre, Saint Cloud, France
    JAMA 293:2367-71. 2005

Collaborators

Detail Information

Publications3

  1. pmc First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
    Chrystelle Brignone
    Immutep SA, 2 rue Jean Rostand, Orsay 91893, France
    J Transl Med 8:71. 2010
    ..We report clinical and biological results of a phase I/II in patients with metastatic breast carcinoma (MBC) receiving first-line paclitaxel weekly, 3 weeks out of 4...
  2. doi Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial
    Etienne G C Brain
    Institut Curie, Hôpital René Huguenin, Saint Cloud, France
    Crit Rev Oncol Hematol 80:160-70. 2011
    ..This multicentre phase II trial was designed to assess the impact of adjuvant anthracycline-based chemotherapy on these patients' autonomy...
  3. ncbi Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancer
    Etienne G C Brain
    Department of Medical Oncology, René Huguenin Cancer Centre, Saint Cloud, France
    JAMA 293:2367-71. 2005
    ..Adjuvant chemotherapy with new cytotoxic agents for breast cancer must be properly assessed for toxicity...